Skip to main content

STROKE-LIKE EPISODES EN CDG: PROPUESTA MULTICENTRICA INTERNACIONAL PARA DESCUBRIR EL VERDADERO FENOTIPO, MEJORAR EL DIAGNOSTICO Y TRATAMIENTO Y ENTENDER LOS MECANISMOS SUBYACENTES.

PI21/00068

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2021
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARA LA INVESTIGACION Y DOCENCIA SANT JOAN DE DEU
Execution centre HOSPITAL SAN JUAN DE DIOS ESPLUGUES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exploring a circulating miRNA signature for PMM2-CDG: Initial insights toward diagnosis, stratification, and monitoring

  • Epifani, Florencia
  • Cabus, Lluc|||0000-0003-3068-4135
  • Nolasco, Gregorio A.
  • Bolasell, Mercè
  • Pérez, Jennifer
  • Alcalá, Adrián
  • Fernández, Patricia
  • Lizano, Esther|||0000-0003-3304-9807
  • Márquez, Gisela
  • Belmonte, Sonia
  • Carbonell-Sala, Sílvia
  • Lagarde, Julien
  • Curado, Joao
  • Hernando Davalillo, Cristina
  • Serrano, Mercedes|||0000-0002-2056-2428
Phosphomannomutase deficiency (PMM2-CDG) is the most common congenital disorder of glycosylation, characterized by variable early-onset neurological (hypotonia, cerebellar syndrome, developmental delay) and multi-organ manifestations. Although several clinical trials are ongoing, current biomarkers lack prognostic or monitoring utility. Emerging transcriptomic studies suggest dysregulated pathways in PMM2-CDG, but miRNAs, key gene expression regulators, remain unexplored. This cross-sectional study aims to investigate a circulating miRNA signature that may distinguish PMM2-CDG patients from unaffected controls, providing an initial framework for future studies on potential predictive and monitoring tools. Differential gene expression analysis was used to identify significant differentially expressed (DE) miRNAs, while machine learning models (LASSO, XGBoost) were applied to create an miRNA predictive signature. Dysregulated miRNA pathways analysis provided insights into affected tissues and cellular mechanisms. An optimized protocol addressing challenges in pediatric blood samples was implemented. miRNA profiles from blood samples of 28 PMM2-CDG patients and 67 unaffected controls were analyzed, identifying six DE miRNAs. Regarding machine learning models, XGBoost achieved the best performance (AUC 0.917). Biological analysis revealed that DE miRNAs influence neurological, endocrinological, immunological, and cellular pathways related to the PMM2-CDG phenotype. Notably, miR-122-5p emerged as a highly predictive marker, indicating liver and neurological involvement. Circulating miRNAs represent a promising, minimally invasive avenue for further investigation. While preliminary evidence of their potential diagnostic utility is provided, additional validation in larger and more diverse populations is required to determine their relevance for clinical stratification or monitoring in PMM2-CDG, contributing to future biomarker-driven personalized medicine efforts in this disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Untangling adaptive functioning of PMM2-CDG across age and its impact on parental stress, a cross-sectional study

  • Epifani, Florencia
  • Pujol Serra, Susana María
  • Llorens, Marta|||0000-0001-8532-0115
  • Balcells, Sol
  • Nolasco, Gregorio
  • Bolasell, Mercè
  • Aguilera-Albesa, Sergio|||0000-0003-3540-1448
  • Cancho Candela, Ramon
  • Cuevas Cervera, José Luis
  • García Sánchez, Verónica
  • García Campos, Óscar
  • Miranda-Herrero, María Concepción
  • Moreno-Lozano, Pedro J.
  • Robles, Bernabé
  • Roldán Aparicio, Susana
  • Velázquez Fragua, Ramón
  • Serrano, Mercedes|||0000-0002-2056-2428
Phosphomannomutase deficiency (PMM2-CDG) leads to cerebellar atrophy with ataxia, dysmetria, and intellectual deficits. Despite advances in therapy, the cognitive and adaptive profile remains unknown. Our study explores the adaptive profile of 37 PMM2-CDG patients, examining its association with parental stress and medical characteristics. Assessment tools included ICARS for the cerebellar syndrome and NPCRS for global disease severity. Behavioral and adaptive evaluation consisted of the Vineland Adaptive Behavior Scale and the Health of the Nation Outcome Scales. Psychopathological screening involved the Child Behavior Checklist and the Symptom Check-List-90-R. Parental stress was evaluated using Parental Stress Index. Results were correlated with clinical features. No significant age or sex differences were found. 'Daily living skills' were notably affected. Patients severely affected exhibited lower adaptive skill values, as did those with lipodystrophy and inverted nipples. Greater severity in motor cerebellar syndrome, behavioral disturbances and the presence of comorbidities such as hyperactivity, autistic features and moderate-to-severe intellectual disability correlated with greater parental stress. Our study found no decline in adaptive abilities. We provide tools to assess adaptive deficits in PMM2-CDG patients, emphasizing the importance of addressing communication, daily living skills, and autonomy, and their impact on parental stress in clinical monitoring and future therapies.